Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Jonathan P. Lacro"'
Publikováno v:
The Mental Health Clinician
The mental health clinician, vol 7, iss 3
The mental health clinician, vol 7, iss 3
Introduction: There are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with ora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fcae0ee89438a63c80ded90f4518b2a
http://europepmc.org/articles/PMC6007563
http://europepmc.org/articles/PMC6007563
Autor:
Jonathan P. Lacro, Marcia Valenstein, Reid D. Landes, Dinesh Mittal, Dilip V. Jeste, Mark J. Edlund, Richard R. Owen
Publikováno v:
Clinical schizophreniarelated psychoses. 2(4)
This pilot study tested the feasibility, acceptability, and effect sizes of a multimodal, individual intervention designed to optimize antipsychotic medication use in patients ≥40 years of age with schizophrenia or schizoaffective disorder. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320ade10f08ad3d0e5578241f914d11e
https://pubmed.ncbi.nlm.nih.gov/31009960
https://pubmed.ncbi.nlm.nih.gov/31009960
Publikováno v:
Open Forum Infectious Diseases
Background Recent studies have given rise to the concern that some integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy may lead to weight gain in PLWH. The objectives of this study were to compare the incidence of weight gain fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c179b655efb5576504f1211148193ad2
https://doi.org/10.1093/ofid/ofaa439.1235
https://doi.org/10.1093/ofid/ofaa439.1235
Publikováno v:
Journal of Addiction Medicine. 8:415-420
OBJECTIVE Substance use disorders are a key concern among US veterans. Substance use disorder pharmacotherapies with support for effectiveness are limited. Buprenorphine/naloxone (Suboxone) is an effective opioid replacement treatment option for opio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7e13cdddb968440c64792bd3d5368c
https://doi.org/10.1097/adm.0000000000000071
https://doi.org/10.1097/adm.0000000000000071
Autor:
Douglas E. Faries, Xiaomei Peng, Christian R. Dolder, Jonathan P. Lacro, Baojin Zhu, Haya Ascher-Svanum
Publikováno v:
Patient preference and adherence
OBJECTIVE To compare adherence and persistence to typical versus atypical antipsychotics and between specific atypical agents in the usual care of schizophrenia and to examine the association between adherence and persistence. METHOD Data were drawn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708ce25a320ddce0f819981c1197e487
http://europepmc.org/articles/PMC2770396
http://europepmc.org/articles/PMC2770396
Publikováno v:
Bipolar Disorders. 9:636-645
Objectives: To present the rationale, development, and pilot study of a medication adherence skills training (MAST-BD) intervention for older adults with bipolar disorder (BPD). We developed a 12-week manualized group intervention that combined educa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799e94fc5c5fadb8680571a5babbbc0d
https://doi.org/10.1111/j.1399-5618.2007.00397.x
https://doi.org/10.1111/j.1399-5618.2007.00397.x
Publikováno v:
Psychosomatics. 46:135-141
The authors compared antihypertensive medication adherence and blood pressure control among middle-aged and older outpatients with schizophrenia and related those with psychotic disorders versus persons without any psychiatric illness. A total of 178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cbad30cdeb692b2117780660f0c9311
https://doi.org/10.1176/appi.psy.46.2.135
https://doi.org/10.1176/appi.psy.46.2.135
Publikováno v:
Journal of Clinical Psychopharmacology. 23:389-399
Antipsychotic nonadherence is an important barrier to the successful treatment of schizophrenia and can lead to clinical and economic burdens. Interventions capable of significantly improving medication adherence in patients with schizophrenia would
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90179b21cf699698f87103d032e582c9
https://doi.org/10.1097/01.jcp.0000085413.08426.41
https://doi.org/10.1097/01.jcp.0000085413.08426.41
Publikováno v:
Psychosomatic Medicine. 65:156-162
Objective The prevalence and consequences of nonadherence to antipsychotic medications in schizophrenia and related psychotic disorders have been well described; however, little is known about adherence to medications for nonpsychiatric conditions in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aee2b15e30398a97be0e8fac1294452
https://doi.org/10.1097/01.psy.0000040951.22044.59
https://doi.org/10.1097/01.psy.0000040951.22044.59
Autor:
Michael P. Caligiuri, Kathleen A. Warren, Merri Marini, Dilip V. Jeste, Douglas Galasko, Jonathan P. Lacro, William Samuel, Fauzia Simjee McClure
Publikováno v:
International Journal of Geriatric Psychiatry. 15:794-802
In several retrospective post-mortem studies, patients meeting clinical criteria for Alzheimer's disease (AD) who gained the greatest cognitive benefit from treatment with an acetylcholinesterase (AChE) inhibitor were found to have neocortical Lewy b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b422b99c562e598341ae86842d3ac87f
https://doi.org/10.1002/1099-1166(200009)15:9<794::aid-gps178>3.0.co
https://doi.org/10.1002/1099-1166(200009)15:9<794::aid-gps178>3.0.co